https://harwoodpe.co.uk/harwood-private-equity-invests-in-cyprotex-plc/
Harwood Private Equity invests in Cyprotex | Harwood Private Equity
Jan 27, 2023 - Cyprotex PLC is a leading pharmaceutical contract research company. It is an outsourced provider of in-vitro and in-silico analysis of the activity of...
private equityharwoodinvestscyprotex
https://www.evotec.com/sciencepool/pk-prediction-for-early-drug-discovery-simon-thomas-cyprotex
PK Prediction for Early Drug Discovery- Simon Thomas, Cyprotex - Evotec
Learn about exciting new developments in pharmacokinetic prediction, and how to transform your use of ADME data
early drug discoverysimon thomaspkpredictioncyprotex
https://www.evotec.com/solutions/drug-discovery-preclinical-development/cyprotex-adme-tox-solutions/adme-pk/drug-metabolism/time-dependent-cyp-inhibition-ic50-shift
Time Dependent CYP Inhibition (IC50 Shift) | Cyprotex | Evotec
Cyprotex's Cytochrome P450 Time Dependent Inhibition IC50 Shift assay is able to identify both reversible and time-dependent inhibitors and discriminate...
timedependentcypinhibitionshift
https://www.evotec.com/news/cyprotex-an-evotec-company-joins-new-european-h2020-research-project
Cyprotex, an Evotec company, joins new European H2020 research project - Evotec
cyprotexevoteccompanyjoinsnew
https://discovery.patsnap.com/company/apredica/
Cyprotex US LLC:Company Profile & Technical Research,Competitor Monitor,Market Trends - Discovery |...
us llccompany profiletechnical research